1. Home
  2. ADC vs BIO Comparison

ADC vs BIO Comparison

Compare ADC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agree Realty Corporation

ADC

Agree Realty Corporation

HOLD

Current Price

$79.98

Market Cap

9.6B

Sector

Real Estate

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$259.59

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADC
BIO
Founded
1971
1952
Country
United States
United States
Employees
90
7450
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ADC
BIO
Price
$79.98
$259.59
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$83.35
$358.50
AVG Volume (30 Days)
1.1M
253.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.94
$2.51
Revenue Next Year
$8.44
$3.17
P/E Ratio
$43.33
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$68.98
$211.43
52 Week High
$82.08
$343.12

Technical Indicators

Market Signals
Indicator
ADC
BIO
Relative Strength Index (RSI) 58.23 33.79
Support Level $70.94 $251.00
Resistance Level $82.08 $264.68
Average True Range (ATR) 1.28 7.95
MACD -0.37 -0.51
Stochastic Oscillator 44.22 2.34

Price Performance

Historical Comparison
ADC
BIO

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: